Trelleborg Launches BioPharmaPro Range

The family of products, materials, and services are focused on fluid path single-use equipment.

Katie Hobbins, Managing Editor

July 28, 2023

1 Min Read
chromatography equipment with advanced composite columns
Image courtesy of Trelleborg

Trelleborg Healthcare and Medical has launched a new family of products, materials, and services for fluid path single-use equipment, called BioPharmaPro. The range uses a portfolio of materials including silicones and other elastomers, thermoplastics, and composites which can be manufactured into tubing, custom molded components, and processing columns up to full assemblies.

BioPharmaPro, according to Trelleborg, uses advanced manufacturing technologies like extrusion, molding, composites, and other technologies produced in ISO 7 and ISO 8 cleanrooms. Among the standard cleanliness and biocompatibility requirements needed to product the line, the company also highlighted that it meets BioPhorum Operations Groups Extractables and Leachables standards for silicone tubing.

“Trelleborg’s BioPharmaPro adds value for customers through our one-stop shop for complete integrated solutions, from simple products to complex assemblies, allowing system suppliers to focus on drug development while outsourcing the product engineering and consolidating their supply chain,” said Mike Urbanski, business development manager biopharma at Trelleborg.

The BioPharmaPro range includes platinum-cured silicone tubing, braided hose which are reinforced for higher pressure applications, fittings for tubing and connectors, and vulcanized and non-vulcanized sheeting. The line also has liquid silicone rubber parts that are available in complex geometries, multi-component parts in one bonded solution, advanced composite materials, and engineered grade molded thermoplastic parts.

“BioPharmaPro’s combination of polymer materials expertise, advanced manufacturing processes, innovative engineering, and quality assurance enables us to provide unsurpassed support to accelerate the business of our biopharmaceutical customers,” said Florance Veronelli, segment manager healthcare and medical Europe at Trelleborg.

About the Author(s)

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like